Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10183942
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 10174018
Protein kinase inhibitors
granted -
US 10173985
Aminoindazole derivatives as sodium channel inhibitors
granted -
US 10172844
Use of CDK9 inhibitors to reduce cartilage degradation
granted -
US 10172789
Compositions for transdermal delivery of mTOR inhibitors
granted -
US 10172840
Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof
granted -
US 10167292
Benzodiazepines as bromodomain inhibitors
granted -
US 10167259
Allosteric inhibitors of proteasome and methods of use thereof
granted -
US 10166216
Substituted triazoles useful as Axl inhibitors
granted -
US 10160753
Indazole compounds as IRAK4 inhibitors
granted -
US 10160760
Compounds useful as inhibitors of ATR kinase
granted -
US 10155789
Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
granted -
US 10151756
Predictive markers for polyamine inhibitor cancer therapies
granted -
US 10150783
Heterocyclic ITK inhibitors for treating inflammation and cancer
granted -
US 10144930
Inhibitors of MYH7B and uses thereof
granted -
US 10138486
Inhibitors of DEK protein and related methods
granted -
US 10137121
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10138255
Piperazine derivatives as HIV protease inhibitors
granted -
US 10137100
Administration of serine protease inhibitors to the stomach
granted -
US 10130623
Tyrosine kinase inhibitors
granted -
US 10131659
Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof
granted -
US 10132810
Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor
granted -
US 10130642
Neprilysin inhibitors
granted -
US 10130618
Pharmaceutical combinations of dabigatran and proton pump inhibitors
granted